Figure 8 | Scientific Reports

Figure 8

From: A Long-Term and Slow-Releasing Hydrogen Sulfide Donor Protects against Myocardial Ischemia/Reperfusion Injury

Figure 8

Myocardial injury and in vivo H2S levels evaluation at 24 h or 72 h after reperfusion and administration of GYY4137 and DATS-MSN. Changes in serum creatine kinase MB (CK-MB) (A) and Troponin-I (B) levels at 24 h after reperfusion; (C) Representative mid-myocardial cross sections of TTC-stained hearts and (D) percentage of area at risk (AAR) to total LV and infarction area (INF) to AAR; Representative M-mode images (E) and ejection fraction (F) from each group at 72 h after reperfusion; H2S levels during 12 h after reperfusion in plasma (G), and at 24 h (H) and 72 h (I) after reperfusion in plasma and in myocardium were measured. #P < 0.05 compared with the DATS-MSN group (mean ± SEM, n = 6).

Back to article page